INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA
Instituto
Poznan University of Medical Sciences
Posnania, PoloniaPublicaciones en colaboración con investigadores/as de Poznan University of Medical Sciences (6)
2024
-
Comparative Efficacy of Talquetamab vs. Current Treatments in the LocoMMotion and MoMMent Studies in Patients with Triple-Class-Exposed Relapsed/Refractory Multiple Myeloma
Advances in Therapy, Vol. 41, Núm. 4, pp. 1576-1593
2023
-
Cilta-cel or Standard Care in Lenalidomide-Refractory Multiple Myeloma
New England Journal of Medicine, Vol. 389, Núm. 4, pp. 335-347
-
Healthcare-associated infection prevention and control learning and teaching processes in european higher education institutions – a qualitative study
Pielęgniarstwo Polskie, Núm. 3, Vol. 89, pp. 91-101
2022
-
Innovative Educational Approach in Healthcare-Associated Infection Prevention and Control. Results of a European Study
Lecture Notes in Bioengineering
-
LocoMMotion: a prospective, non-interventional, multinational study of real-life current standards of care in patients with relapsed and/or refractory multiple myeloma
Leukemia, Vol. 36, Núm. 5, pp. 1371-1376
2017
-
Long-term survival of patients with CLL after allogeneic transplantation: A report from the European Society for Blood and Marrow Transplantation
Bone Marrow Transplantation, Vol. 52, Núm. 3, pp. 372-380